drugset / Trial / NCT03201796
Prulifloxacin in Chronic Bacterial Prostatitis (CBP)
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of the study is to assess the efficacy and safety of prulifloxacin in comparison to levofloxacin in the treatment of patients affected by CBP.
Timeline
- Start
- 2016-02-02
- Primary completion
- 2020-05-19
- Completion
- 2020-05-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Levofloxacin | Small molecule | 500 mg | Oral |
| Subject | Prulifloxacin | Small molecule | 600 mg | Oral |